Alzheimer’s disease (AD) is the most common disease in developed countries and affects more than half of the population in low- and middle-income countries. In the past decade, studies have shown that biological and sociological factors have a significant effect on the occurrence and development of AD. Among them, genetic and environmental factors, pathophysiological characteristics, and unhealthy lifestyle factors cause the neurological symptoms. Among them, the risk factors of cognitive decline in the elderly caused by lifestyle can be intervened in the early stage. If some adults can overcome these risk factors as early as possible, they can predict that they will gradually reduce their cognitive impairment over time, and the likelihood ...
In the absence of curative therapies for Alzheimer’s disease (AD), primary prevention strategies are...
Alzheimer’s disease (AD) and other forms of dementia are a growing public health problem among the e...
Alzheimer’s Disease (AD) is a neurodegenerative disorder with a decades-long preclinical phase. Prec...
Alzheimer’s disease (AD) is the most common disease in developed countries and affects more than hal...
One of the consequences of the worldwide population aging phenomenon is the increasing number of the...
Alzheimer Disease (AD) is the most common type of dementia worldwide and is a progressive neurodegen...
Research on prevention strategies have shown promising results for delaying onset of Alzheimer\u27s ...
We investigated whether dementia risk factors were associated with prodromal Alzheimer's disease (AD...
The prevalence of Alzheimer’s disease among population worldwide is increasing because of unrecogniz...
We investigated whether dementia risk factors were associated with prodromal Alzheimer’s disease (AD...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
The objective is to study risk factors for Alzheimer disease (AD) in Istanbul, Turkey. This is a pop...
Alzheimer’s disease (AD) is a neurodegenerative condition which consists of stages of mental, memory...
Introduction: Previous research has identified modifiable risk factors for Alzheimer’s disease (AD) ...
As the number of patients with Alzheimer\u27s disease (AD) is expected to grow, finding ways to prev...
In the absence of curative therapies for Alzheimer’s disease (AD), primary prevention strategies are...
Alzheimer’s disease (AD) and other forms of dementia are a growing public health problem among the e...
Alzheimer’s Disease (AD) is a neurodegenerative disorder with a decades-long preclinical phase. Prec...
Alzheimer’s disease (AD) is the most common disease in developed countries and affects more than hal...
One of the consequences of the worldwide population aging phenomenon is the increasing number of the...
Alzheimer Disease (AD) is the most common type of dementia worldwide and is a progressive neurodegen...
Research on prevention strategies have shown promising results for delaying onset of Alzheimer\u27s ...
We investigated whether dementia risk factors were associated with prodromal Alzheimer's disease (AD...
The prevalence of Alzheimer’s disease among population worldwide is increasing because of unrecogniz...
We investigated whether dementia risk factors were associated with prodromal Alzheimer’s disease (AD...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
The objective is to study risk factors for Alzheimer disease (AD) in Istanbul, Turkey. This is a pop...
Alzheimer’s disease (AD) is a neurodegenerative condition which consists of stages of mental, memory...
Introduction: Previous research has identified modifiable risk factors for Alzheimer’s disease (AD) ...
As the number of patients with Alzheimer\u27s disease (AD) is expected to grow, finding ways to prev...
In the absence of curative therapies for Alzheimer’s disease (AD), primary prevention strategies are...
Alzheimer’s disease (AD) and other forms of dementia are a growing public health problem among the e...
Alzheimer’s Disease (AD) is a neurodegenerative disorder with a decades-long preclinical phase. Prec...